Autoimmune disorders and interleukin-2 therapy: a step toward 'unanswered questions'.
Wolkenstein
P
P
Revuz
J
J
Guillaume
J C
JC
Avril
M F
MF
Chosidow
O
O
D001327:Autoimmune Diseases / Q000209:etiology*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000628:therapy; D008875:Middle Aged; D010392:Pemphigus / Q000209:etiology / Q000276:immunology; D012878:Skin Neoplasms / Q000628:therapy; D014820:Vitiligo / Q000209:etiology / Q000276:immunology
D007376:Interleukin-2